Orexo Ab Stock Market Value
| ORXOF Stock | USD 3.23 0.00 0.00% |
| Symbol | Orexo |
Orexo AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Orexo AB's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Orexo AB.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Orexo AB on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Orexo AB or generate 0.0% return on investment in Orexo AB over 90 days. Orexo AB is related to or competes with Shield Therapeutics, Pacific Edge, Grown Rogue, Biosyent, Cannara Biotech, and Jushi Holdings. Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the ... More
Orexo AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Orexo AB's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Orexo AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0665 | |||
| Maximum Drawdown | 5.9 |
Orexo AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Orexo AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Orexo AB's standard deviation. In reality, there are many statistical measures that can use Orexo AB historical prices to predict the future Orexo AB's volatility.| Risk Adjusted Performance | 0.1316 | |||
| Jensen Alpha | 0.1476 | |||
| Total Risk Alpha | 0.0357 | |||
| Treynor Ratio | 1.46 |
Orexo AB January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1316 | |||
| Market Risk Adjusted Performance | 1.47 | |||
| Mean Deviation | 0.3254 | |||
| Coefficient Of Variation | 571.29 | |||
| Standard Deviation | 0.9586 | |||
| Variance | 0.9188 | |||
| Information Ratio | 0.0665 | |||
| Jensen Alpha | 0.1476 | |||
| Total Risk Alpha | 0.0357 | |||
| Treynor Ratio | 1.46 | |||
| Maximum Drawdown | 5.9 | |||
| Skewness | 5.65 | |||
| Kurtosis | 31.0 |
Orexo AB Backtested Returns
At this point, Orexo AB is somewhat reliable. Orexo AB maintains Sharpe Ratio (i.e., Efficiency) of 0.18, which implies the firm had a 0.18 % return per unit of risk over the last 3 months. We have found seventeen technical indicators for Orexo AB, which you can use to evaluate the volatility of the company. Please check Orexo AB's Coefficient Of Variation of 571.29, risk adjusted performance of 0.1316, and Variance of 0.9188 to confirm if the risk estimate we provide is consistent with the expected return of 0.18%. Orexo AB has a performance score of 14 on a scale of 0 to 100. The company holds a Beta of 0.11, which implies not very significant fluctuations relative to the market. As returns on the market increase, Orexo AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Orexo AB is expected to be smaller as well. Orexo AB right now holds a risk of 0.98%. Please check Orexo AB coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day typical price , to decide if Orexo AB will be following its historical price patterns.
Auto-correlation | 0.22 |
Weak predictability
Orexo AB has weak predictability. Overlapping area represents the amount of predictability between Orexo AB time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Orexo AB price movement. The serial correlation of 0.22 indicates that over 22.0% of current Orexo AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Currently Active Assets on Macroaxis
Other Information on Investing in Orexo OTC Stock
Orexo AB financial ratios help investors to determine whether Orexo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Orexo with respect to the benefits of owning Orexo AB security.